Oncolys BioPharma (TSE:4588) Total Liabilities : 円446.65 Mil (As of Dec. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Oncolys BioPharma Total Liabilities?

Oncolys BioPharma's Total Liabilities for the quarter that ended in Dec. 2024 was 円446.65 Mil.

Oncolys BioPharma's quarterly Total Liabilities increased from Mar. 2024 (円395.58 Mil) to Jun. 2024 (円468.72 Mil) but then declined from Jun. 2024 (円468.72 Mil) to Dec. 2024 (円446.65 Mil).

Oncolys BioPharma's annual Total Liabilities increased from Dec. 2022 (円491.69 Mil) to Dec. 2023 (円566.50 Mil) but then declined from Dec. 2023 (円566.50 Mil) to Dec. 2024 (円446.65 Mil).

Oncolys BioPharma Total Liabilities Historical Data

The historical data trend for Oncolys BioPharma's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncolys BioPharma Total Liabilities Chart

Oncolys BioPharma Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

793.09

697.88

491.69

566.50

446.65

Oncolys BioPharma Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Dec24
Total Liabilities	Get a 7-Day Free Trial															454.14	566.50	395.58	468.72	446.65

Oncolys BioPharma Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Oncolys BioPharma's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	252.39	+	(186.687	+	0.0020000000000024
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	7.57	+	0)
	=	446.65

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	3198.858	-	2752.209
	=	446.65

Oncolys BioPharma's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	252.39	+	(186.687	+	0.0020000000000024
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	7.57	+	0)
	=	446.65

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	3198.858	-	2752.209
	=	446.65

Oncolys BioPharma Total Liabilities Related Terms

Thank you for viewing the detailed overview of Oncolys BioPharma's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncolys BioPharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncolys BioPharma Inc (TSE:4588) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

4-1-28 Toranomon, Toranomon Towers Office, Minato-ku, Tokyo, JPN, 105-0001

Website

http://www.oncolys.com

Oncolys BioPharma Inc develops pharmaceutical products. The company is engaged in research and development of oncolytic viruses, drugs for serious infectious diseases, molecular targeted anti-cancer drugs, and tumor diagnostic agents.

Oncolys BioPharma Headlines

No Headlines